Nuvisan Pharma Services Selects ALPHADAS To Accelerate Clinical Development Processes

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that NUVISAN Pharma Services (“NUVISAN”) has purchased the ALPHADAS® clinical trials software solution suite for deployment in its Phase I unit located in Neu-Ulm, Germany.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC